These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1931709)

  • 1. Is interferon alpha in cutaneous T-cell lymphoma a treatment of choice?
    Papa G; Tura S; Mandelli F; Vegna ML; Defazio D; Mazza P; Zinzani PL; Simoni R; DePita O; Ferranti G
    Br J Haematol; 1991 Oct; 79 Suppl 1():48-51. PubMed ID: 1931709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon alpha-2a in cutaneous T-cell lymphoma.
    Vegna ML; Papa G; Defazio D; Pisani F; Coppola G; De Pità O; Puddu P; Ferranti G; Simoni R; Mandelli F
    Eur J Haematol Suppl; 1990; 52():32-5. PubMed ID: 2279544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome.
    Foss FM; Ihde DC; Linnoila IR; Fischmann AB; Schechter GP; Cotelingam JD; Steinberg SM; Ghosh BC; Stocker JL; Bastian A
    J Clin Oncol; 1994 Oct; 12(10):2051-9. PubMed ID: 7931473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy of cutaneous T cell lymphoma with interferon alpha-2a and photochemotherapy.
    Stadler R; Otte HG
    Recent Results Cancer Res; 1995; 139():391-401. PubMed ID: 7597306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the Sézary syndrome.
    Kuzel TM; Roenigk HH; Samuelson E; Herrmann JJ; Hurria A; Rademaker AW; Rosen ST
    J Clin Oncol; 1995 Jan; 13(1):257-63. PubMed ID: 7799028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndrome.
    Kohn EC; Steis RG; Sausville EA; Veach SR; Stocker JL; Phelps R; Franco S; Longo DL; Bunn PA; Ihde DC
    J Clin Oncol; 1990 Jan; 8(1):155-60. PubMed ID: 2295906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant leukocyte interferon alfa-2a in the treatment of mycosis fungoides.
    Simoni R; Cavalieri R; Coppola G; Ricciotti L; De Pità O; Criscuolo D; Covelli A; Papa G; Mandelli F
    J Biol Regul Homeost Agents; 1987; 1(2):93-9. PubMed ID: 3504088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up in 51 patients with mycosis fungoides and Sézary syndrome treated by interferon-alfa.
    Jumbou O; N'Guyen JM; Tessier MH; Legoux B; Dréno B
    Br J Dermatol; 1999 Mar; 140(3):427-31. PubMed ID: 10233261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas.
    Bunn PA; Ihde DC; Foon KA
    Cancer; 1986 Apr; 57(8 Suppl):1689-95. PubMed ID: 3485012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined modality therapy for cutaneous T-cell lymphoma.
    Duvic M; Lemak NA; Redman JR; Eifel PJ; Tucker SL; Cabanillas FF; Kurzrock R
    J Am Acad Dermatol; 1996 Jun; 34(6):1022-9. PubMed ID: 8647968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon alfa-2a maintenance after salvage autologous stem cell transplantation in atypical mycosis fungoides with central nervous system involvement.
    Doerschner M; Pekar-Lukacs A; Messerli-Odermatt O; Dommann-Scherrer C; Rütti M; Müller AM; Nair G; Kamarachev J; Kerl K; Beer M; Messerli M; Frauenknecht K; Haralambieva E; Hoetzenecker W; French LE; Guenova E
    Br J Dermatol; 2019 Dec; 181(6):1296-1302. PubMed ID: 30565216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma.
    Marolleau JP; Baccard M; Flageul B; Rybojad M; Laroche L; Vérola O; Brandely M; Morel P; Gisselbrecht C
    Arch Dermatol; 1995 May; 131(5):574-9. PubMed ID: 7741545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alpha interferon in the therapy of cutaneous T cell lymphomas].
    Lang MH; Altmeyer P; Lodemann E; Holzmann H
    Z Hautkr; 1986 May; 61(9):599-608. PubMed ID: 3487184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and safety of interferon α-2a combined with phototherapy for patients with early-stage mycosis fungoides - a single-arm prospective study in 13 patients.
    Song H; Hu Z; Zhang S; Yang L; Feng J; Lu L; Liu Y; Wang T
    J Dermatolog Treat; 2024 Dec; 35(1):2350231. PubMed ID: 38754985
    [No Abstract]   [Full Text] [Related]  

  • 15. Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA.
    Mostow EN; Neckel SL; Oberhelman L; Anderson TF; Cooper KD
    Arch Dermatol; 1993 Jun; 129(6):747-52. PubMed ID: 8507078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of cutaneous lymphoma--current practice and future developments.
    Dummer R; Kempf W; Hess Schmid M; Häffner A; Burg G
    Onkologie; 2003 Aug; 26(4):366-72. PubMed ID: 12972705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous T-cell lymphoma.
    Lansigan F; Choi J; Foss FM
    Hematol Oncol Clin North Am; 2008 Oct; 22(5):979-96, x. PubMed ID: 18954747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma.
    Roenigk HH; Kuzel TM; Skoutelis AP; Springer E; Yu G; Caro W; Gilyon K; Variakojis D; Kaul K; Bunn PA
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):198S-205S. PubMed ID: 2258636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Juvenile mycosis fungoides with large-cell transformation: Successful treatment with psoralen with ultraviolet A light, interferon-alfa, and localized radiation.
    Chan WH; Lewis DJ; Hinojosa T; Curry JL; Duvic M
    Pediatr Dermatol; 2018 Jan; 35(1):e13-e16. PubMed ID: 29159918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Dose Intralesional Recombinant Interferon-α2b in the Treatment of Mycosis Fungoides.
    Hu JK; Carlson K; Girardi M
    Yale J Biol Med; 2020 Mar; 93(1):41-44. PubMed ID: 32226334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.